Medical network on August 31 - an aging population, rural population structural factors such as population urbanization and domestic environment pollution increasing incidence of lung cancer, lung cancer in China has become the number one cause of mortality and morbidity of malignant tumor diseases.
At present, the domestic anti-lung cancer drug market has become blue sea, companies are laying out the layout, trying to share a piece of the soup.On the one hand, as the CFDA, issued the decision of adjust the imported drug registration management related matters (draft) ", from regulators simplifies the overseas unlisted new drugs into China a number of restrictions, on the other hand first imitation products are also beginning to listed companies in our country, the market of the smoke is everywhere!
|
